InvestorsHub Logo
icon url

massulo52

11/30/20 8:24 PM

#312396 RE: JBWIN #312392

Best news in years. Notice the Jury Trial.
icon url

Biobillionair

11/30/20 8:26 PM

#312398 RE: JBWIN #312392

Thanks. Now this is the fight, not that bullshit Judge Du mishandled practice case.
BB
icon url

Biobillionair

11/30/20 8:42 PM

#312409 RE: JBWIN #312392

AMARIN FILES INFRINGEMENT SUIT!! see here:
Thanks JBWIN.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159812837

icon url

Biobillionair

11/30/20 8:55 PM

#312423 RE: JBWIN #312392

Makes me think reading this “ Amarin and Mochida”.... a large BP might take both companies out. BB
icon url

circuitcity

11/30/20 9:32 PM

#312467 RE: JBWIN #312392

Great news, also feel interesting to see mochida here and wondering what is the implication here.

One thought I can think of by bundling with mochida is that it may be harder for people to use Jelis as a prior art to invalidate reduceit patents.
icon url

ilovetech

11/30/20 10:23 PM

#312495 RE: JBWIN #312392

JBWIN, thanks for sharing. To my layman's understanding, it reads very compellingly. Fish wants revenge, and it looks like he pulled all stops.

ILT
icon url

sts66

12/01/20 4:58 PM

#312721 RE: JBWIN #312392

AMRN didn't file for a temporary injunction, only a permanent one - do they have to ask for a temp injunction in a separate filing? Because they won't stop Hikma from selling GV with a permanent one until the case and all appeals are heard several years from now.

End of radio silence from AMRN - going after Hikma with all barrels blazing - and Singer is involved from the start this time, same firm represented GSK in the Teva patent infringement case.

Only question I have is since the PR's AMRN claims show intent to infringe by encouraging docs to prescribe GV off label for CVD are gone from the web, likely that no docs saw them either - so how does their prior existence influence docs now and in the future?